DK122885B - Analogifremgangsmåde til fremstilling af 1,4-dihydropyridinderivater. - Google Patents

Analogifremgangsmåde til fremstilling af 1,4-dihydropyridinderivater.

Info

Publication number
DK122885B
DK122885B DK118268AA DK118268A DK122885B DK 122885 B DK122885 B DK 122885B DK 118268A A DK118268A A DK 118268AA DK 118268 A DK118268 A DK 118268A DK 122885 B DK122885 B DK 122885B
Authority
DK
Denmark
Prior art keywords
preparation
analogous process
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
DK118268AA
Other languages
Danish (da)
English (en)
Inventor
F Bossert
W Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK122885B publication Critical patent/DK122885B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK118268AA 1967-03-20 1968-03-19 Analogifremgangsmåde til fremstilling af 1,4-dihydropyridinderivater. DK122885B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1670824A DE1670824C3 (de) 1967-03-20 1967-03-20 1,4-Dihydropyridin-33-dicarbonsäurealkylester

Publications (1)

Publication Number Publication Date
DK122885B true DK122885B (da) 1972-04-24

Family

ID=7104981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK118268AA DK122885B (da) 1967-03-20 1968-03-19 Analogifremgangsmåde til fremstilling af 1,4-dihydropyridinderivater.

Country Status (15)

Country Link
US (2) US3488359A (de)
AT (1) AT275521B (de)
BE (1) BE712482A (de)
CH (1) CH515236A (de)
DE (1) DE1670824C3 (de)
DK (1) DK122885B (de)
ES (1) ES351795A1 (de)
FI (1) FI49300C (de)
FR (2) FR1579533A (de)
GB (1) GB1173104A (de)
IL (1) IL29569A (de)
NL (1) NL156922B (de)
NO (1) NO123804B (de)
SE (1) SE337374B (de)
YU (1) YU32926B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152285B (da) * 1975-07-02 1988-02-15 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
US3971790A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3971791A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US4038399A (en) * 1972-04-18 1977-07-26 Bayer Aktiengesellschaft 1,4-dihydropyridine carboxylic acid esters useful as coronary vessel dilators and anti-hypertensives
US4136187A (en) * 1972-08-12 1979-01-23 Bayer Aktiengesellschaft Antihypertensive 2-amino-4,5-dihydropyridine derivatives
DE2239815C2 (de) * 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US3985376A (en) * 1973-06-04 1976-10-12 Basf Aktiengesellschaft Dye precursors for pressure-sensitive recording material
US3956341A (en) * 1974-02-21 1976-05-11 Smithkline Corporation 1,3,5-Tricarbo-1,4-dihydropyridines
CH607848A5 (de) * 1974-06-04 1978-11-30 Bayer Ag
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
GB2111978B (en) * 1981-10-19 1985-05-01 Maruko Pharmaceutical Co 1 4-dihydropyridine compounds
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
FR2596760B1 (fr) * 1986-04-02 1988-12-09 Sori Soc Rech Ind Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique
US4954346A (en) * 1988-06-08 1990-09-04 Ciba-Geigy Corporation Orally administrable nifedipine solution in a solid light resistant dosage form
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
DK0595164T3 (da) * 1992-10-30 1997-05-26 Bayer Ag 4-Heterocyclophenyl-substituerede dihydropyridiner
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152285B (da) * 1975-07-02 1988-02-15 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater

Also Published As

Publication number Publication date
US3488359A (en) 1970-01-06
FR1579533A (de) 1969-08-29
DE1670824C3 (de) 1978-08-03
US3574843A (en) 1971-04-13
AT275521B (de) 1969-10-27
GB1173104A (en) 1969-12-03
ES351795A1 (es) 1969-06-16
SE337374B (de) 1971-08-09
BE712482A (de) 1968-09-20
NL6803817A (de) 1968-09-23
NL156922B (nl) 1978-06-15
FI49300C (fi) 1975-05-12
DE1670824B2 (de) 1977-12-01
DE1670824A1 (de) 1971-04-01
IL29569A (en) 1971-12-29
YU32926B (en) 1975-12-31
CH515236A (de) 1971-11-15
NO123804B (de) 1972-01-17
FR7896M (de) 1970-05-04
YU59768A (en) 1975-06-30
FI49300B (de) 1975-01-31

Similar Documents

Publication Publication Date Title
DK122885B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridinderivater.
DK136421B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridin-derivater.
DK127113B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridiner.
DK119878B (da) Analogifremgangsmåde til fremstilling af 2-methyl-3-carboxylsyreamido-quinoxalin-di-N-oxider-(1,4).
DK118820B (da) Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
DK129234B (da) Fremgangsmåde til fremstilling af levo-1-n-butyl-2',6'-pipecoloxylidid.
DK123868B (da) Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater.
DK118288B (da) Analogifremgangsmåde til fremstilling af 2-halogenmethyl-3-carboxylsyreamido-quinoxalin-di-N-oxider-(1,4).
DK123232B (da) Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler.
DK118246B (da) Analogifremgangsmåde til fremstilling af 2-isothiuroniummethyl-3-carboxylsyreamido-quinozalin-di-N-oxid-(1,4)-halogenider.
DK118507B (da) Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater.
DK119559B (da) Analogifremgangsmåde til fremstilling af 4-pyrimidyl-1,4-dihydropyridinderivater.
DK119166B (da) Fremgangsmåde til fremstilling af 1,4-bezodiazepinderivater.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
DK126936B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK118291B (da) Analogifremgangsmåde til fremstilling af 10α-alkoxy-9,10-dihydroergolinderivater.
DK123818B (da) Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider.
DK125083B (da) Fremgangsmåde til fremstilling af 2,3-diklor-4-butyryl-fenoxyeddikesyre.
DK137494B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.
DK123476B (da) Fremgangsmåde til fremstilling af 3-oxo-A-nor-B-homo-estra-5(10)-ener.
DK129842B (da) Fremgangsmåde til fremstilling af 3-imino-1,2-benzisothiazoliner.
DK121440B (da) Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.
DK112319B (da) Fremgangsmåde til fremstilling af 7-nitrosubstituerede 1,4-benzodiazepinoner.
DK122175B (da) Analogifremgangsmåde til fremstilling af 3-oxo-13β-alkyl-17α-allyl-17β-hydroxygona-4,9,11-triener.